Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedTrakRx, officially known as MedTrak Services, is a pharmacy benefit management (PBM) company that specializes in providing tailored prescription drug benefit solutions for small to mid-sized employers. The company emphasizes a high-touch service model, focusing on clinical management and cost-containment strategies to help clients manage rising pharmacy expenditures. Originally founded in 1999 and based in Overland Park, Kansas, the firm was acquired by EnvisionRx (a subsidiary of Rite Aid) in 2014 for approximately $215 million. Following Rite Aid's 2023 bankruptcy and subsequent restructuring, the Elixir PBM business, which included MedTrakRx assets, was sold to MedImpact Healthcare Systems in early 2024. Today, it operates as part of the broader MedImpact portfolio, continuing to serve its niche market of self-insured employers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedTrakRx.